Detection of OXA-48-like and NDM carbapenemases producing Klebsiella pneumoniae in Jordan: A pilot study  by Aqel, Amin A. et al.
JJ
D
c
p
A
I
A
a
A
b
A
c
d
e
R
R
J
h
1ARTICLE IN PRESSIPH-547; No. of Pages 6
ournal of Infection and Public Health (2016) xxx, xxx—xxx
etection  of  OXA-48-like  and  NDM
arbapenemases  producing  Klebsiella
neumoniae  in  Jordan:  A  pilot  study
min  A.  Aqela,b,∗,  Panagiota  Giakkoupic,  Hamed  Alzoubia,
brahim  Masalhad,  Matthew  J.  Ellingtone,
lkiviadis  Vatopoulosc
Microbiology  and  Immunology  Department,  Faculty  of  Medicine,  Mu’tah  University,
l-Karak 61710,  Jordan
Al-Ghad  International  Colleges  for  Applied  Medical  Sciences,  Madinah  Branch,  Saudi
rabia
Department  of  Microbiology,  National  School  of  Public  Health,  Athens,  Greece
Medlab  Referral  Department,  Jabal  Amman,  Amman,  Jordan
Public  Health  England,  Antimicrobial  Resistance  and  Healthcare  Associated  Infection
eference Unit,  National  Infection  Service,  61  Colindale  Avenue,  London  NW9  5EQ,  UK
eceived  9  November  2015;  received  in  revised  form  9  February  2016;  accepted  20  February  2016
KEYWORDS
Carbapenemase;
CTX-M;
NDM;
OXA-48-like;
K.  pneumoniae;
Jordan
Summary  Little  is  known  of  carbapenemase  producing  Klebsiella  pneumoniae
(CPK)  in  Jordan.  This  study  aimed  to  determine  the  prevalence  of  CPK  in  a  major
hospital  in  Amman,  Jordan  in  2012—2013  and  to  characterize  the  isolates  and  detect
the  types  of  carbapenemase(s)  they  produced.
For  the  296  isolates  investigated,  species  identiﬁcation  and  antimicrobial  suscep-
tibilities  were  determined  (Vitek  II,  bioMérieux).  Isolates  with  decreased  ertapenem
susceptibility  were  tested  for  carbapenemase  production  using  the  Modiﬁed  Hodge
Test.  Isolates  with  a  carbapenemase-positive  phenotype  were  characterized  further
via  multiplex  PCRs  for  extended-spectrum  -lactamase  and  carbapenemase  genesPlease  cite  this  article  in  press  as:  Aqel  AA,  et  al.  Detection  of  OXA-48-like  and  NDM  carbapenemases
producing  Klebsiella  pneumoniae  in  Jordan:  A  pilot  study.  J  Infect  Public  Health  (2016),
http://dx.doi.org/10.1016/j.jiph.2016.02.002
and  by  Pulsed  Field  Gel  Electrophoresis  (PFGE).
Seven  of  296  K.  pneumoniae  isolated  in  2012—2013  (2.4%)  were  carbapenemase
producers,  ﬁve  produced  class  D  carbapenemases  (OXA-48-like)  and  two  produced  a
NDM  metallo-beta-lactamase.  All  seven  isolates  also  encoded  CTX-M  enzymes;  CTX-
M-1-like  enzymes  were  detected  in  ﬁve  isolates  (two  co-producing  NDM  enzymes  and
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three  co-producing  OXA-48-like  enzymes),  CTX-M-9  was  found  in  the  two  remaining
OXA-48-like  producers.  PFGE  revealed  ﬁve  genetically  distinct  types  amongst  the
seven  carbapenemase  producing  K.  pneumoniae, with  two  pairs  of  identical  isolates
associated  with  patients  treated  on  the  same  wards.
The  emergence  of  OXA-48-like  and  NDM  carbapenemases  associated  with  multi-drug
resistant  (MDR)  isolates  in  Jordan  is  concerning.  The  strict  implementation  of  infection
lp  to  disrupt  the  spread  of  MDR  carbapenemase  producers  in
dulaziz  University  for  Health  Sciences.  All  rights  reserved.
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Modiﬁed  Hodge  Test  (MHT)  [11]  was  performed  on
suspected carbapenemase  producers  according  to
CLSI guidelines  (2014)  [10], with  K.  pneumoniaecontrol  practices  will  he
Jordanian  hospitals.
© 2016  King  Saud  Bin  Ab
Introduction
Carbapenem  antimicrobials  are  the  drugs  of  choice
for severe  infections  caused  by  multidrug  resistant
Gram-negative  bacteria  [1].  Carbapenem-resistant
Enterobacteriaceae  (CRE)  can  cause  treatment  fail-
ure and  constitute  an  important  public  health
problem [2].  Resistance  due  to  the  production
of a  carbapenemase  is  horizontally  transferred
amongst Enterobacteriaceae  and  the  types  of  car-
bapenemase  are  myriad;  clavulanic-acid-inhibited
-lactamases  (Class  A:  KPC,  NMC,  IMI,  SME,  and
GES);  metallo--lactamases  (Class  B:  IMP,  VIM,  NDM,
GIM, SPM,  and  SIM)  and  expanded-spectrum  oxacil-
linases  (Class  D:  OXA-48-like)  [3].
European  surveillance  data  have  indicated  the
incidence  of  carbapenem-resistant  Klebsiella  pneu-
moniae to  be  low  (less  than  0.5%)  in  many  Northern
European countries  including  Finland,  Denmark,
Ireland and  Sweden  in  2014.  By  contrast  Italy  and
Greece  had  endemic  problems  with  frequencies  of
34.3% in  Italy  and  59.4%,  respectively  (*EARS-Net
interactive database:  http://ecdc.europa.eu/en/
healthtopics/antimicrobial  resistance/database/
Pages/table  reports.aspx) [4].  Elsewhere,
carbapenemase-producing  Klebsiella  (CPK)  are
considered  endemic  in  the  North  East  of  the  USA,
Puerto  Rico,  Zhejiang  Province  of  China,  Southern
Asia, and  parts  of  the  Middle  East,  while  very  few
cases  have  been  reported  from  Australia  and  Africa
[5].  In  Jordan  and  other  Arabian  countries  the
isolation rates  for  CPK  range  between  2%  and  10%
[6—8]  and  OXA-48  and  NDM-1  enzymes  are  known
to predominate  amongst  Enterobacteriaceae  in
Morocco,  Palestine  and  the  Arabian  Gulf  countries
[6,7,9].  While  Jordanian  hospitals,  including  our
own, do  receive  medical  cases  referred  from  other
Arabian  countries,  little  is known  of  the  prevalencePlease  cite  this  article  in  press  as:  Aqel  AA,  et  al.  D
producing  Klebsiella  pneumoniae  in  Jordan:  A  
http://dx.doi.org/10.1016/j.jiph.2016.02.002
of CPK  infections,  their  outcomes  and  the  degree
of spread  amongst  hospital  patients  [8]. This
pilot study  aimed  to  determine  the  frequency  of
A
1
rnfections  due  to  CPK  and  to  characterize  the
solates and  the  carbapenemase  enzymes  they
ncode  in  order  to  determine  the  molecular  epi-
emiology  of  CPK  amongst  effected  patients  in  a
ajor Jordanian  teaching  hospital.
aterials and methods
acterial isolates
rom  March  2012  to  April  2013,  296  K. pneumo-
iae were  isolated  from  clinical  specimens  (blood
ulture,  urine,  ﬂuid,  wound,  tissue  and  sputum)
aken from  296  patients  attending  Islamic  Hospital
hich  is  a  450  bed  hospital  in  Amman,  Jordan.  Iso-
ates were  identiﬁed  and  tested  for  susceptibility
o a panel  of  antimicrobials  (Vitek  II,  bioMérieux),
he results  for  the  latter  were  interpreted  accord-
ng the  Clinical  and  Laboratory  Standards  Institute
CLSI)  guidelines,  2014  [10].
creening for carbapenemase producing
solates
solates  with  decreased  susceptibility  to  cefoxitin
IC ≥16  g/ml,  ceftazidime  MIC  ≥8  g/ml,  cefo-
axime MIC  ≥2  g/ml,  imipenem  MIC  >1  mg/l,  or
eropenem  MIC  >1  mg/ml  were  investigated  for
arbapenemase  activity  [11]. Also,  isolates  with
ecreased  susceptibility  to  ertapenem  (zones  of
1 mm  or  less  around  a  10  g  ertapenem  disk)  were
nvestigated as  possible  carbapenemase  produc-
rs according  to  CLSI  guidelines  (2014)  [10].  Theetection  of  OXA-48-like  and  NDM  carbapenemases
pilot  study.  J  Infect  Public  Health  (2016),
TCC BAA-1705  and  K.  pneumoniae  ATCC  BAA-
706 used  as  positive  and  negative  control  strains,
espectively.
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XA-48-like  and  NDM  detection  in  K.  pneumoniae  
ultiplex-PCRs for -lactamase and
arbapenemase genes
rude  DNA  lysates  were  prepared  by  suspending
 1  L  loop-full  of  freshly  cultured  cells  in  200  L
f sterile  distilled  water.  The  suspension  was  incu-
ated for  5  min  at  95 ◦C  and  1  L  of  supernatant
rom the  centrifuged  lysates  used  as  template  DNA
or PCR.  Genes  encoding  CTX-M  extended  spec-
rum -lactamases  were  detected  via  multiplex
CR [12], carbapenemase  gene  families  (blaNDM,
laVIM,  blaIMP,  blaKPC,  blaOXA-48-like)  were  deter-
ined according  to  Giakkoupi  et  al.  [13].
ulsed-ﬁeld gel electrophoresis (PFGE)
FGE  was  performed  to  determine  the  clonal  rela-
ionships  between  the  isolates  using  CHEF-DR  III
pparatus  from  Bio-Rad  Laboratories  (Richmond,
A, USA).  Brieﬂy,  chromosomal  DNA  embedded  into
eaKem Gold  Agarose  (Lonza,  Rockland,  USA)  was
igested  overnight  with  XbaI  (New  England  Biolabs,
A, USA).  Digested  DNA  was  electrophoresed  in  1%
garose (Biorad,  CA,  USA)  at  6  V/cm  for  20  h;  the
ulse time  was  increased  from  5 to  55  s.  DNA  was
isualized  and  imaged  under  UV  light  after  stain-
ng with  GelRed  dye  (Biotium,  San  Francisco,  USA).
FGE bands  in  the  gel  image  were  detected  in  Gel
ompar  II  software  (v.  3.1b)  (Applied  Math,  Kor-
rijk,  Belgium)  and  the  banding  patterns  of  each
solate  compared  using  the  unweighted  pair  group
ethod  with  arithmetic  averages  clustering  method
y using  the  Dice  coefﬁcient.
esults
even  of  the  296  K.  pneumoniae  (2.8%)  were  car-
apenemase  producers  (CPK).  The  isolates  were
ecovered  from  various  specimens  from  three
ordanian, two  Syrian  and  two  Yemeni  patients
Table  1).  The  isolates  were  all  resistant  to
moxicillin/clavulanic  acid,  ticarcillin/clavulanic
cid, piperacillin,  piperacillin/tazobactam,  cefo-
axime, cefepime,  ciproﬂoxacin  and  gentamicin
n addition  to  the  carbapenems.  Susceptibil-
ty to  tetracycline  (42.8%),  amikacin  (28.5%)
nd trimethoprim/sulfamethoxazole  (28.5%)  varied
etween the  isolates.  All  seven  isolates  were  sus-
eptible  to  tigecycline  and  colistin  (Table  1).
PCR ampliﬁcation  of  the  carbapenemase,  and
TX-M extended-spectrum  -lactamase  genesPlease  cite  this  article  in  press  as:  Aqel  AA,  et  al.  D
producing  Klebsiella  pneumoniae  in  Jordan:  A  
http://dx.doi.org/10.1016/j.jiph.2016.02.002
evealed that  two  of  the  seven  CPK  harbored
 blaNDM gene  and  ﬁve  harbored  a blaOXA-48-like
ene  (Table  1).  Both  of  the  isolates  that  had  a
p
t
t PRESS
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laNDM gene  also  harbored  a  group  9 blaCTX-M gene
CTX-M-9-like).  Likewise,  two  of  the  ﬁve  isolates
ith a blaOXA-48-like gene  also  harbored  a group  9
laCTX-M gene,  while  the  remaining  three  isolates
ith a blaOXA-48-like gene  had  a group  1  CTX-M
blaCTX-M-1-like) ESBL.  All  isolates  were  negative  for
laVIM, blaIMP and  blaKPC. Phenotypic  inhibition
ests were  in  accordance  with  the  molecular
ndings (data  not  shown).
The  seven  CPK  isolates  were  classiﬁed  into  three
nrelated PFGE  types  (A,  B,  C)  with  similarity
ercentages <80%.  Type  A  was  further  divided  to
ubtypes (A1,  A2,  A3)  (Fig.  1).  Types  A1  (isolates  2
nd 3)  and  A3  (isolates  7 and  8)  represented  pairs
f PFGE  identical  isolates  that  were  isolated  from
ifferent  patients  (from  Jordan,  Yemen  and  Syria)
hat had  were  treated  on  the  same  wards  in  our
ospital.
iscussion
xtended-spectrum  -lactamases  (ESBLs)  are  pro-
uced by  half  of  the  K.  pneumoniae  isolates  in
ordan [14]  which  has  driven  the  widespread  use
f carbapenems.  Despite  the  high  value  of  car-
apenems  as  an  empirical  treatment  against  serious
nfections  due  to  ESBL  producers,  recent  work  has
hown that  5.6%  of  the  Gram-negative  isolates  in
ordan were  carbapenem  resistant  [8]. Here,  our
nding of  carbapenemase  production  in  2.8%  of
012—2013  isolates  is  lower  than  published  rates
n Europe  or  the  USA,  but  does  agree  with  reported
arbapenemase rates  from  other  Arabian  countries
6,15].  Furthermore,  we  identiﬁed  multiple  NDM
roducers  as  well  as  a predominance  of  OXA-48-
ike producers,  indicating  that  Jordan  faces,  at  the
ery least,  the  same  level  of  challenge  to  carbapen-
ms as  other  countries  in  the  Arabian  Gulf  as  well
s the  wider  region  (e.g.  Palestine,  Lebanon,  Egypt
nd Turkey)  [6,9,16,17]. The  methods  we  used  for
henotypically  detecting  carbapenemase  produc-
rs were  according  to  the  published  standards  that
ere current  at  the  time  [11]; however,  updated
ethods for  the  detection  of  metallo-enzyme  types
s well  as  for  OXA-48-like  enzymes  will  improve
ase ascertainment  and  thus  the  determined  rate
f carbapenemase  producers  still  further.  Never-
heless,  the  identiﬁcation  of  these  two  distinct
pidemic enzyme  types  highlights  the  urgent  need
or continued  study  and  surveillance  of  carbapene-
ase producers  in  Jordan,  not  least  to  improve  theetection  of  OXA-48-like  and  NDM  carbapenemases
pilot  study.  J  Infect  Public  Health  (2016),
oor ascertainment  of  carbapenemase  producers
hat is  associated  with  standard  front-line  diagnos-
ic laboratory  workﬂows  which  do  not  speciﬁcally
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Table  1  Metadata,  antimicrobial  susceptibilities  and  molecular  characteristics  of  the  seven  carbapenemase  producing  K.  pneumoniae.
Code
No.a
Isolation  date  Location  Specimen  Sex  Age  Carbapenemase
and  CTX-M  gene
families
PFGE
group
Antibiotic  susceptibility  patternb
FOX  CAZ  ATM  AMK  TET  SXT  TIG  COL  CARB
1  JO  13/04/2013  Internal
medicine
ward
Urine  M  75  bla  OXA-48-like,
blaCTX-M-1-like
B  R  R  R  R  R  R  S S R
2  SYR  16/04/2013  ICU  Sputum  M  31  bla  OXA-48-like,
blaCTX-M-9-like
A3  I  I R  R  S  R  S S R
3  SYR 06/03/2013  ICU  Abdominal
ﬂuid
M  32  bla  OXA-48-like,
blaCTX-M-9-like
A3  I  I R  R  S  R  S S R
4  JO  27/03/2012  ICU  Tissue  M  30  bla  NDM,
blaCTX-M-1-like
C  R  R  S R  R  R  S S R
6  YEM  28/03/2012  Surgical
ward
Tissue  F  36  bla  NDM,
blaCTX-M-1-like
A2  R  R  R  R  S  R  S S R
7  YEM  24/03/2012  Internal
medicine
ward
Blood  M  20  bla  OXA-48-like,
blaCTX-M-1-like
A1  R  R  R  S R  S  S S R
8  JO  05/04/2012  Internal
medicine
ward
Blood  F  73  bla  OXA-48-like,
blaCTX-M-1-like
A1  R  R  R  S R  S  S S R
a JO, Jordanian; SYR, Syrian; YEM, Yemeni; M, male; F, Female; ICU, intensive care unit.
b FOX, cefoxitin; CAZ, ceftazidime; ATM, aztreonam; AMK, amikacin; TET, tetracycline; SXT, trimethoprim/sulfamethoxazole; TIG, tigecycline; COL, colistin, CARB, carbapenem
drugs (imipenem, doripenem, ertapenem, meropenem). (S)ensitive/(I)ntermediate/(R)esistant interpretations according to CLSI 2014.
ARTICLE IN PRESSJIPH-547; No. of Pages 6
OXA-48-like  and  NDM  detection  in  K.  pneumoniae  5
Figure  1  The  genetic  relatedness  of  the  seven  CPK  isolated  in  Amman,  Jordan.  Dendrogram  of  percentage  relatedness
in  the  PFGE  banding  patterns  shows  types  A,  B,  and  C,  and  the  sub-types  A1,  A2,  A3  (annotated)  indicating  the  diversity
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Sresent  amongst  the  2  NDM  and  5  OXA-48-like  produci
epartment;  ICU,  intensive  care  unit;  Abd,  abdominal.
eek  the  detection  of  ESBL  and/or  carbapenemase
henotypes  or  genes  [18].
In this  ﬁrst  report  of  NDM  and  OXA-48-like  CPK
n Jordan  we  found  isolates  in  multiple  patients
f three  different  nationalities,  hospitalized  in  a
ingle center.  The  two  NDM-1  producers  were  clas-
iﬁed into  different  PFGE  types  A2  and  C.  The  type
2 isolate  was  from  a  Yemeni  patient  while  the
ype C  isolate  was  from  a  native  Jordanian  with
o travel  history,  but  both  were  hospitalized  at  the
ame time.  The  NDM  positivity  of  these  distinct
solates may  reﬂect  the  horizontal  transfer  of  an
DM encoding  plasmid  or  the  endemicity  of  NDM
roducing  isolates  in  Jordan  and  Yemen.  Indeed,
nternational transfer  of  NDM  gene(s)  has  been  con-
rmed in  Europe  and  the  USA  [19,20].  The  ﬁve
XA-48 producers  were  classiﬁed  into  PFGE  types
 and  B.  Type  B  was  represented  by  a  single  iso-
ate from  a  Jordanian  patient.  Within  PFGE  type  A,
ub-types A1  and  A3  each  comprised  two  isolates.
solates from  subtype  A3  were  from  two  Syrian
atients treated  in  ICU  at  different  times,  and
ay reﬂect  repeated  introductions  of  the  bacterial
train by  Syrian  patients  or  by  a  lapse  in  infection
ontrol measures.  The  type  A1  isolates  were  from,
rst a  Yemeni  patient,  followed  by  a  native  Jorda-
ian  treated  on  the  same  ward  only  12  days  apart
nd may  reﬂect  the  importance  of  strict  implemen-
ation of  infection  prevention  measures.  CTX-1  and
TX-M-9 type  ESBLs  predominate  amongst  ESBL  pro-
ucers in  Jordan  [14]  and  they  were  found  to  be
ndemic  amongst  the  OXA-48-like  and  NDM  CPK  we
dentiﬁed In  terms  of  possible  remaining  treatment
ptions for  the  MDR  isolates  we  were  able  to  con-Please  cite  this  article  in  press  as:  Aqel  AA,  et  al.  D
producing  Klebsiella  pneumoniae  in  Jordan:  A  
http://dx.doi.org/10.1016/j.jiph.2016.02.002
rm tetracycline  as  a  possible  treatment  option  for
42.8% of  the  isolates)  while  tigecycline  and  colistin
oth remained  as  solid  treatment  options  against
he carbapenemase  producers  we  detected.
N
p
N
W.  pneumoniae. No.,  isolates  numbers;  Path,  pathology
In  summary,  this  pilot  study  aimed  to  determine
he molecular  epidemiology  of  carbapenemase  pro-
ucing K.  pneumoniae  that  occur  in  Jordan.  While
e found  some  evidence  for  clonal  spread  of
PK in  our  center  our  data  were  predominated
y distinct  carbapenemase  genes  and  unrelated
acterial strains  and  likely  reﬂects  the  endemi-
ity of  such  organisms  in  our  patient  population.
mproved surveillance  of  resistance  and  the  genetic
eterminants  of  resistance  must  now  be  a  prior-
ty for  multidrug  resistant  Enterobacteriaceae  in
ordan and  across  our  region.  Adhering  to  exten-
ive infection  control  measures  in  community  and
ospital-acquired  infections  will  help  disrupt  the
urther spread  of  carbapenemase  producing  iso-
ates among  hospitalized  patients  in  Jordan.
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